BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6599115)

  • 1. Correlation between plasma carcinoembryonic antigen (CEA) and sialyltransferase as tumor marker.
    Dwivedi C; Dixit M; Hardy RE
    J Med; 1984; 15(5-6):379-84. PubMed ID: 6599115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sialyltransferase in patients with breast cancer.
    Lee YT; Tokes ZA; Csipke CP
    J Surg Oncol; 1980; 14(2):159-65. PubMed ID: 7392638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of sialyltransferase as a tumour marker.
    De AK; Hardy RE
    Indian J Biochem Biophys; 1990 Dec; 27(6):452-5. PubMed ID: 2102490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-sialyltransferase activity in cancer patients.
    Berge PG; Wilhelm A; Schriewer H; Wüst G
    Klin Wochenschr; 1982 May; 60(9):445-9. PubMed ID: 7045508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum glycosyl transferases and carcinoembryonic antigen in patients with colorectal carcinoma in different stages.
    Ronquist G; Rimsten A; Blanche C; Cervén E; Hiesche C; Westman M
    Acta Chir Scand; 1982; 148(4):373-7. PubMed ID: 7136442
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-operative serum sialyltransferase levels and prognosis in breast cancer.
    Stewart J; Rubens R; Millis R; Hayward J; Hoare S; Bulbrook R; Kessel D
    Breast Cancer Res Treat; 1983; 3(2):225-30. PubMed ID: 6616079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor.
    Bauvois B; Cacan R; Fournet B; Caen J; Montreuil J; Verbert A
    Eur J Biochem; 1982 Jan; 121(3):567-72. PubMed ID: 7035171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in plasma sialyltransferase levels in patients with neoplastic disease.
    Henderson M; Kessel D
    Cancer; 1977 Mar; 39(3):1129-34. PubMed ID: 912650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in serum sialyltransferase activities in patients with brain tumors.
    Shen AL; Chou MD; Chi CW; Lee LS
    Surg Neurol; 1984 Nov; 22(5):509-14. PubMed ID: 6495162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elevated serum-sialyltransferase activity in human malignant diseases: a new diagnostic tool? (author's transl)].
    Ganzinger U; Dorner F; Unger FM; Moser K; Jentzsch K
    Klin Wochenschr; 1977 Jun; 55(11):553-5. PubMed ID: 881775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present value of tumor markers in the clinic.
    Pohl AL; Francesconi M; Ganzinger UC; Graninger W; Lenzhofer RS; Moser KV
    Cancer Detect Prev; 1983; 6(1-2):7-20. PubMed ID: 6192922
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors.
    Ganzinger U; Deutsch E
    Cancer Res; 1980 Apr; 40(4):1300-4. PubMed ID: 7357558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on sialyltransferase isoenzymes in plasma of patients with breast cancer.
    Kessel DH; Chou TH; Coombes RC
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1035-40. PubMed ID: 7198984
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma sialyltransferase as a tumor marker.
    Dwivedi C; Dixit M; Hardy RE
    Cancer Detect Prev; 1988; 11(3-6):191-6. PubMed ID: 3390843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma.
    Kithier K; Samal B; Cejka J; Whitcomb MP; Mood DW
    Tumour Biol; 1988; 9(6):307-14. PubMed ID: 3206109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of different tumor markers in breast cancer and gynecological malignancies.
    Kreienberg R; Koehler P; Kasemeyer R; Melchert F
    Cancer Detect Prev; 1983; 6(1-2):221-5. PubMed ID: 6603907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum sialyltransferase follow up control of malignant diseases].
    Ganzinger U; Euler-Rolle J; Baumgartner G; Pawlak E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1212-5. PubMed ID: 206046
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum sialyltransferase activity in benign and malignant diseases.
    Ronquist G; Rimsten A; Westman M; Cervén E
    Acta Chir Scand; 1980; 146(4):247-52. PubMed ID: 7468050
    [No Abstract]   [Full Text] [Related]  

  • 20. Seminal plasma levels of fucosyltransferase, galactosyltransferase and sialyltransferase in normospermic and oligospermic men.
    Ronquist G
    Urol Int; 1987; 42(2):143-7. PubMed ID: 3113024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.